Inspired by recent research on insulin-induced gene 2 (INSIG2) as a novel biomarker for colon cancer, Kayashima et al. attempted to study the involvement of INSIG2 in pancreatic malignancy. This evidence concerns the gene INSIG2 and colonic neoplasm.